Philana Ling Lin Selected Research

Philana Ling Lin Research Topics

Disease

30	Tuberculosis (Tuberculoses) 12/2023 - 06/2004
26	Infections 03/2024 - 08/2005
21	Granuloma 12/2023 - 06/2004
4	Inflammation (Inflammations) 03/2024 - 01/2016
4	Reinfection 03/2024 - 10/2018
4	Pneumococcal Infections 08/2018 - 04/2003
4	Latent Infection 08/2012 - 10/2007
3	Pneumonia (Pneumonitis) 01/2017 - 08/2014
2	Coinfection 03/2024 - 12/2023
2	Pulmonary Tuberculosis 11/2023 - 01/2020
2	Latent Tuberculosis 05/2011 - 08/2005
1	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 01/2020
1	Virus Diseases (Viral Diseases) 01/2020
1	Lung Injury 01/2020
1	Pneumococcal Pneumonia 06/2017
1	Pneumococcal Meningitis (Streptococcus pneumoniae Meningitis) 09/2015
1	Extensively Drug-Resistant Tuberculosis 12/2014
1	Chronic Granulomatous Disease 03/2009
1	Impetigo (Impetigo Contagiosa) 03/2009
1	Persistent Infection 05/2007

Drug/Important Bio-Agent (IBA)

11	CytokinesIBA 03/2024 - 08/2005
9	VaccinesIBA 11/2023 - 01/2012
7	Anti-Bacterial Agents (Antibiotics)IBA 03/2024 - 12/2014
7	Conjugate VaccinesIBA 08/2018 - 04/2003
5	AntigensIBA 12/2023 - 01/2012
5	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2016 - 08/2005
4	RNA (Ribonucleic Acid)IBA 12/2023 - 01/2018
4	Proteins (Proteins, Gene)FDA Link 12/2023 - 07/2013
3	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2021 - 12/2016
3	Interleukin-17 (Interleukin 17)IBA 01/2016 - 01/2015
2	LigandsIBA 12/2023 - 06/2004
2	Transcription Factors (Transcription Factor)IBA 01/2023 - 01/2022
2	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 09/2013
2	Linezolid (Zyvox)FDA Link 01/2020 - 12/2014
2	Biomarkers (Surrogate Marker)IBA 10/2018 - 04/2016
2	Interleukin-10 (Interleukin 10)IBA 01/2016 - 01/2016
2	Interleukin-2 (IL2)IBA 01/2016 - 01/2016
2	Interferon-gamma (Interferon, gamma)IBA 10/2009 - 07/2006
2	ChemokinesIBA 08/2005 - 06/2004
1	Immunoglobulin IsotypesIBA 12/2023
1	Immunoglobulin M (IgM)IBA 12/2023
1	Immunoglobulin G (IgG)IBA 12/2023
1	Immunoglobulin A (IgA)IBA 12/2023
1	arabinomannanIBA 12/2023
1	Polysaccharides (Glycans)IBA 12/2023
1	AntibodiesIBA 12/2023
1	ProteomeIBA 12/2023
1	Interleukin-15 (Interleukin 15)IBA 12/2023
1	Immunodominant EpitopesIBA 01/2023
1	Moxifloxacin (Avelox)FDA Link 01/2023
1	Formyl Peptide Receptors (Formyl Peptide Receptor)IBA 01/2021
1	BCG Vaccine FDA Link 01/2020
1	InterferonsIBA 01/2020
1	Interleukin-1 (Interleukin 1)IBA 01/2020
1	Rifampin (Rifampicin)FDA LinkGeneric 01/2020
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 01/2020
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 01/2020
1	Granzymes (Granzyme)IBA 01/2020
1	AerosolsIBA 01/2019
1	DNA (Deoxyribonucleic Acid)IBA 10/2018
1	Interleukin-6 (Interleukin 6)IBA 01/2016
1	Neutralizing AntibodiesIBA 01/2016
1	Rituximab (Mabthera)FDA Link 01/2016
1	Indicators and Reagents (Reagents)IBA 03/2015
1	Oxazolidinones (2 Oxazolidone)IBA 12/2014
1	Therapeutic UsesIBA 12/2014
1	Drug CombinationsIBA 09/2013
1	Nitric Oxide Synthase (NO Synthase)IBA 07/2013
1	ArginaseIBA 07/2013
1	Protein Isoforms (Isoforms)IBA 07/2013
1	EnzymesIBA 07/2013
1	Oxygen (Dioxygen)IBA 08/2012
1	Metronidazole (Metric)FDA LinkGeneric 08/2012
1	Isoniazid (Ftivazide)FDA LinkGeneric 05/2011
1	Interleukin-4 (Interleukin 4)IBA 03/2011
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 02/2010
1	Adalimumab (Humira)FDA Link 02/2010
1	CC ChemokinesIBA 06/2004

Therapy/Procedure

7	Therapeutics 02/2024 - 10/2007
2	Transplantation 05/2017 - 02/2017
1	Art Therapy 10/2020
1	Intravenous Administration 01/2020
1	Drug Therapy (Chemotherapy) 09/2013
1	Duration of Therapy 08/2012
1	Aftercare (After-Treatment) 01/2012
1	Cholecystectomy 03/2009